Phase III study of AKP-01 spray in mild to moderate plaque psoriasis meets primary endpoint Jan. 27, 2020
Abeona initiates phase III study of EB-101 in recessive dystrophic epidermolysis bullosa Jan. 14, 2020
Positive topline data from phase Ib study of CBP-201 in moderate to severe atopic dermatitis Jan. 9, 2020
Novan reports topline efficacy data from phase III B-SIMPLE program of SB-206 for molluscum Jan. 3, 2020
RSS